Integrated Treatment for Mood and Substance Use Disorders

213 Pages·2003·3.982 MB·English

by  Joseph J. Westermeyer, Roger D. Weiss, Douglas M. Ziedonis

Integrated Treatment for Mood
and Substance Use Disorders

Integrated Treatment for Mood
and Substance Use Disorders
Edited by
Joseph J. Westermeyer, M.D., M.P.H., Ph.D.
Professor, Department ofPsychiatry, University ofMinnesota
ChiefofPsychiatry and Mental-Behavioral Health Service Director,
VA Medical Center, Minneapolis, Minnesota
Roger D. Weiss, M.D.
Associate Professor ofPsychiatry, Harvard Medical School,
Boston, Massachusetts
Clinical Director, Alcohol and Drug Abuse Treatment Program,
McLean Hospital, Belmont, Massachusetts
Douglas M. Ziedonis, M.D., M.P.H.
Associate Professor and Director, Division ofAddiction Psychiatry,
Robert Wood Johnson Medical School, Piscataway, New Jersey
    
Baltimore & London
© 2003 The Johns Hopkins University Press
All rights reserved. Published 2003
Printed in the United States of America on acid-free paper
9 8 7 6 5 4 3 2 1
The Johns Hopkins University Press
2715 North Charles Street
Baltimore, Maryland 21218-4363
www.press.jhu.edu
Library of Congress Cataloging-in-Publication Data
Integrated treatment for mood and substance use disorders /edited by Joseph J.
Westermeyer, Roger D. Weiss, and Douglas M. Ziedonis.
p. ; cm.
Includes bibliographical references and index.
ISBN 0-8018-7199-9 (hardcover : alk. paper)
1. Substance abuse—Treatment. 2. Affective disorders—Treatment. 3. Dual
diagnosis.
[DNLM: 1. Mood Disorders—therapy. 2. Diagnosis, Dual (Psychiatry).
3. Mood Disorders—complications. 4. Substance-Related Disorders—
complications. 5. Substance-Related Disorders—therapy. WM 171 1585 2003]
I. Westermeyer, Joseph, 1937– II. Weiss, Roger D., 1951– III. Ziedonis, Douglas.
RC564 .1546 2003
616.85(cid:1)2706—dc21 2002007591
A catalog record for this book is available from the British Library.
With love to those whose support permitted us to participate in
this creative effort:
Rachel Westermeyer, Michelle Westermeyer, and Joe Westermeyer
Margaret Griffin, Emily Weiss, and Alexander Weiss
Patrice Ziedonis, Michelle Ziedonis, and Mason Ziedonis

Contents
Acknowledgments ix
List of Contributors xi
1 Addressing Co-occurring Mood and Substance Use Disorders 1
Joseph J. Westermeyer
2 Understanding the Problem of Co-occurring Mood and
Substance Use Disorders 17
Melissa P. DelBello and Stephen M. Strakowski
3 The Assessment of Mood and Substance Use Disorders 42
Shelly F. Greenfield
4 Integrated Treatment Using a Recovery-Oriented Approach 68
Dennis C. Daley, Ihsan M. Salloum, and Michael E. Thase
5 Dual Recovery Therapy: Blending Psychotherapies for
Depression and Addiction 90
Douglas M. Ziedonis and Jonathan A. Krejci
viii Contents
6 Pharmacotherapy for Co-occurring Mood and Substance
Use Disorders 122
Roger D. Weiss
7 Evaluating and Managing Patients Who Are Not Responding
to Treatment 140
Jill M. Williams and Caroline Eick
8 Addressing Tobacco Dependence in Integrated Treatment 161
John Slade and Betty Vreeland
Resources 185
Index 191
Acknowledgments
The editors acknowledge funding from numerous sources during the prepara-
tion of this volume.
For Joseph Westermeyer, sources include: principal investigator, “Devel-
opment and Pilot Study of a Daily Symptom Chart for PTSD,” Bristol-Squibb
(developmental grant) (1996–2000); principal investigator (Jose Canive,
M.D., co–principal investigator), “Delivery of Mental Health Services for
PTSD and Alcoholism to American Indian and Hispanic American Veterans
in New Mexico and Minnesota,” VA Merit Review grant (1997–2000); co–
principal investigator (James Jaranson, M.D., principal investigator), “Popula-
tion-Based Survey of Torture and Violence [in African Refugees],” NIH grant
(1998–2003); site principal investigator, multisite study, “Double Blind Con-
trolled Study of Venlafaxin (Effexor) in the Treatment of PTSD,” Wyeth-Ayerst
(2001–2003). Dr. Westermeyer’s employment during these grants involved
funds from the Minneapolis VA Medical Center and the University of Min-
nesota Department of Psychiatry.
For Roger Weiss, sources include National Institute on Drug Abuse Grants
DA00326 and DA09400 and the Dr. Ralph and Marian C. Falk Medical Re-
search Trust.
For Douglas Ziedonis, sources include National Institute of Drug Abuse,
Center for Substance Abuse Treatment, and Robert Wood Johnson Foundation.